73Indexed trials
Market Rank #39 · Evidence Tier A
Hong Kong
Neuroscience Intelligence
Hong Kong neuroscience intelligence: 73 indexed trials, 9 institutions, research score 30.88.
25Recruiting
9Research institutions
30.9Research score
Evidence profile
18Sponsors
14Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 30.9 · Data confidence 100.00 · Evidence 30.9
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
autism12trials
depression9trials
alzheimers9trials
adhd8trials
stroke8trials
epilepsy6trials
parkinsons5trials
schizophrenia4trials
neuro_oncology3trials
dementia_other3trials
Leading indexed sponsors
The Hong Kong Polytechnic University19trials
Chinese University of Hong Kong17trials
The University of Hong Kong13trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.5trials
Merck Sharp & Dohme LLC3trials
Education University of Hong Kong3trials
Hoffmann-La Roche2trials
Shionogi1trials
Tseung Kwan O Hospital, Hong Kong1trials
UCB BIOSCIENCES, Inc.1trials